Crisis of the Clinical Trials Staff Attrition After the COVID-19 Pandemic
Sun, Grace, Dizon, Don S, Szczepanek, Connie M, Petrylak, Daniel P, Sparks, Dana B, Tangen, Catherine, Lara, Jr, Primo Lucky N, Thompson, Jr, Ian M, Blanke, Charles David
Published in JCO oncology practice (01.08.2023)
Published in JCO oncology practice (01.08.2023)
Get more information
Journal Article
A phase I trial of elimusertib in combination with cisplatin or with cisplatin plus gemcitabine in advanced solid tumors with an emphasis on urothelial carcinoma
Leibrandt, Ryan, Frankel, Paul Henry, Beumer, Jan Hendrik, Takebe, Naoko, Yin, Ming, Emamekhoo, Hamid, Lara, Primo "Lucky" N., Gore, Steven, Parikh, Mamta
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A phase III randomized trial of eribulin (E) with or without gemcitabine versus standard of care (SOC) for metastatic urothelial carcinoma (UC) refractory to or ineligible for PD/PDL1 antibody (Ab): SWOG S1937
Sadeghi, Sarmad, Plets, Melissa, Lara, Primo "Lucky" N., Tangen, Catherine, Bangs, Rick, Lerner, Seth P., Flaig, Thomas W., Petrylak, Daniel P., Thompson, Ian
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A first-in-human, phase I, open-label study of a novel cancer vaccine labvax 3(22)-23 and adjuvant GM-CSF in patients with advanced stage adenocarcinomas
Ma, Weijie, Chen, Shuai, Ogihara, Nancy L., Huynh, Jasmine, Yen, Ariel, Kelly, Karen, Lara, Primo "Lucky" N., Radosevich, James A., Babich, Michael, Li, Tianhong
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
National impact of the COVID-19 pandemic on clinical trial staff attrition: Results of the SWOG Cancer Research Network Survey of Oncology Research Professionals
Dizon, Don S., Szczepanek, Connie M., Petrylak, Daniel P., Sparks, Dana B., Tangen, Catherine, Lara, Primo "Lucky" N., Thompson, Ian M, Blanke, Charles David
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
First-in-human study of TAS3681, an oral androgen receptor (AR) antagonist with AR and AR splice variant (AR-SV) downregulation activity, in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) refractory to abiraterone (ABI) and/or enzalutamide (ENZ) and chemotherapy (CT)
De Bono, Johann S., Cook, Natalie, Yu, Evan Y., Lara, Primo "Lucky" N., Wang, Judy S., Yamasaki, Yoshihiko, Yamamiya, Ikuo, Gao, Ping, Calleja, Elizabeth Martine, Rathkopf, Dana E.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
SWOG S1931 (PROBE): Phase III randomized trial of immune checkpoint inhibitor (ICI) combination regimen with or without cytoreductive nephrectomy (CN) in advanced renal cancer
Vaishampayan, Ulka N., Tangen, Catherine, Tripathi, Abhishek, Shuch, Brian M., Pal, Sumanta K., Barata, Pedro C., Tan, Alan, Zuckerman, Peggy, Mayerson, Edward, Lara, Primo "Lucky" N., Agarwal, Neeraj, Vogelzang, Nicholas J., Kim, Hyung Lae, Thompson, Ian Murchie
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Bone biomarkers and overall survival (OS) in men with advanced hormone-sensitive prostate cancer (HSPC): Results from SWOG S1216, a phase III trial of ADT +/- orteronel
Lara, Primo "Lucky" N., Mayerson, Edward, Gertz, Erik, Tangen, Catherine, Goldkorn, Amir, Van Loan, Marta, Hussain, Maha H. A., Gupta, Shilpa, Zhang, Jingsong, Parikh, Mamta, Twardowski, Przemyslaw, Quinn, David I., Vogelzang, Nicholas J., Thompson, Ian M, Agarwal, Neeraj
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
EVEREST: Everolimus for renal cancer ensuing surgical therapy—A phase III study (SWOG S0931, NCT01120249)
Ryan, Christopher W., Tangen, Catherine, Heath, Elisabeth I., Stein, Mark N., Meng, Maxwell, Alva, Ajjai Shivaram, Pal, Sumanta K., Puzanov, Igor, Clark, Joseph I., Choueiri, Toni K., Agarwal, Neeraj, Uzzo, Robert, Haas, Naomi B., Synold, Timothy W., Plets, Melissa, Vaishampayan, Ulka N., Shuch, Brian M., Vogelzang, Nicholas J., Thompson, Ian M, Lara, Primo “Lucky” N.
Published in Journal of clinical oncology (10.06.2022)
Published in Journal of clinical oncology (10.06.2022)
Get full text
Journal Article
Osimertinib plus necitumumab in EGFR-mutant NSCLC: Final results from an ETCTN California Cancer Consortium phase I study
Riess, Jonathan W., Krailo, Mark D., Padda, Sukhmani Kaur, Groshen, Susan G., Wakelee, Heather A., Reckamp, Karen L., Koczywas, Marianna, Piotrowska, Zofia, Steuer, Conor Ernst, Kim, Chul, Paweletz, Cloud P., Sholl, Lynette M., Heavey, Grace, Kolesar, Jill, Moscow, Jeffrey, Janne, Pasi A., Lara, Primo "Lucky" N., Newman, Edward M., Gandara, David R.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Phase II randomized double blind trial of axitinib (Axi) +/- PF-04518600, an OX40 antibody (PFOX) after PD1/PDL1 antibody (IO) therapy (Tx) in metastatic renal cell carcinoma (mRCC)
Sadeghi, Sarmad, Parikh, Rahul Atul, Tsao-Wei, Denice D., Groshen, Susan G., Li, Ming, Appleman, Leonard Joseph, Tagawa, Scott T., Nanus, David M., Molina, Ana M., Kefauver, Cheryl, Ornstein, Moshe Chaim, Rini, Brian I., Dreicer, Robert, Quinn, David I., Lara, Primo "Lucky" N.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Analysis of homologous recombination DNA repair gene mutation status in patients with metastatic small cell lung cancer treated with cediranib and olaparib on NCI 9881 study
Kim, Joseph W., Radke, Marc R., Hafez, Navid, Soliman, Hatem Hussein, Fu, Siqing, Kato, Shumei, Lara, Primo "Lucky" N., Vaishampayan, Ulka N., Abdul Razak, Albiruni Ryan, Cardin, Dana Backlund, Munster, Pamela N., Eder, Joseph Paul, Shyr, Yu, Ivy, S. Percy, LoRusso, Patricia, Swisher, Elizabeth M.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Sunitinib versus cabozantinib, crizotinib or savolitinib in metastatic papillary renal cell carcinoma (pRCC): Results from the randomized phase II SWOG 1500 study
Pal, Sumanta K., Tangen, Catherine, Thompson, Ian Murchie, Haas, Naomi B., George, Daniel J., Heng, Daniel Yick Chin, Shuch, Brian M., Stein, Mark N., Tretiakova, Maria S., Humphrey, Peter, Adeniran, Adebowale, Narayan, Vivek, Bjarnason, Georg A., Vaishampayan, Ulka N., Alva, Ajjai Shivaram, Zhang, Tian, Cole, Scott Wesley, Plets, Melissa, Wright, John, Lara, Primo "Lucky" N.
Published in Journal of clinical oncology (20.02.2021)
Published in Journal of clinical oncology (20.02.2021)
Get full text
Journal Article
A randomized phase II study comparing cisplatin and gemcitabine with or without berzosertib in patients with advanced urothelial carcinoma
Pal, Sumanta K., Mortazavi, Amir, Milowsky, Matthew I., Vaishampayan, Ulka N., Parikh, Mamta, Lyou, Yung, Wang, Peng, Parikh, Rahul Atul, Teply, Benjamin A., Dreicer, Robert, Emamekhoo, Hamid, Michaelson, M. Dror, Hoimes, Christopher J., Zhang, Tian, Srinivas, Sandy, Kim, William Y., Liu, Glenn, Frankel, Paul Henry, Cui, Yuijie, Lara, Primo "Lucky" N.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Biomarker analysis from a randomized phase II study of olaparib with or without cediranib in men with metastatic castration-resistant prostate cancer (mCRPC)
McKay, Rana R., Radke, Marc R, Shyr, Yu, Zhao, Shilin, Taplin, Mary-Ellen, Davis, Nancy B., Monk, Paul, Appleman, Leonard Joseph, Lara, Primo "Lucky" N., Vaishampayan, Ulka N., Zhang, Jingsong, Paul, Asit K., Bubley, Glenn, Huang, Ying, Shapiro, Geoffrey, LoRusso, Patricia, Ivy, S. Percy, Petrylak, Daniel Peter, Swisher, Elizabeth M., Kim, Joseph W.
Published in Journal of clinical oncology (20.02.2021)
Published in Journal of clinical oncology (20.02.2021)
Get full text
Journal Article
PROSPER: Phase III RandOmized Study Comparing PERioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143)
Allaf, Mohamad E., Kim, Se Eun, Master, Viraj A., McDermott, David F., Signoretti, Sabina, Cella, David, Gupta, Rajan T., Cole, Suzanne, Shuch, Brian M., Lara, Primo "Lucky" N., Kapoor, Anil, Heng, Daniel Yick Chin, Leibovich, Bradley C., Michaelson, M. Dror, Choueiri, Toni K., Jewett, Michael A.S., Maskens, Deb, Harshman, Lauren C, Carducci, Michael Anthony, Haas, Naomi B.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
SWOG S1216: A phase III randomized trial comparing androgen deprivation therapy (ADT) plus TAK-700 with ADT plus bicalutamide in patients (pts) with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC) (NCT01809691)
Agarwal, Neeraj, Tangen, Catherine, Hussain, Maha H. A., Gupta, Shilpa, Plets, Melissa, Lara, Primo "Lucky" N., Harzstark, Andrea, Twardowski, Przemyslaw, Paller, Channing Judith, Zylla, Dylan M., Zibelman, Matthew R., Levine, Ellis Glenn, Roth, Bruce J., Goldkorn, Amir, Vaena, Daniel A., Kohli, Manish, Crispino, Tony, Vogelzang, Nicholas J., Thompson, Ian Murchie, Quinn, David I.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Final results from a phase I trial and expansion cohorts of cabozantinib and nivolumab (CaboNivo) alone or with ipilimumab (CaboNivoIpi) for metastatic genitourinary tumors
Apolo, Andrea B., Girardi, Daniel da Motta, Niglio, Scot Anthony, Nadal, Rosa Maria, Cordes, Lisa M., Steinberg, Seth M., Costello, Rene, Trepel, Jane B, Lee, Sunmin, Lee, Min-Jung, Cao, Liang, Gulley, James L., Bottaro, Donald P., Saraiya, Biren, Pal, Sumanta K., Quinn, David I., Lara, Primo "Lucky" N., Parnes, Howard L., Dahut, William L., Mortazavi, Amir
Published in Journal of clinical oncology (20.02.2021)
Published in Journal of clinical oncology (20.02.2021)
Get full text
Journal Article
Sapanisertib, a dual mTORC1/2 inhibitor, for TSC1- or TSC2- mutated metastatic urothelial carcinoma (mUC)
Kim, Joseph W., Milowsky, Matthew I., Hahn, Noah M., Kwiatkowski, David J., Morgans, Alicia K., Davis, Nancy B., Appleman, Leonard Joseph, Gupta, Sumati, Lara, Primo "Lucky" N., Hoffman-Censits, Jean H., Quinn, David I., Shyr, Yu, LoRusso, Patricia, Sklar, Jeffrey, Petrylak, Daniel Peter
Published in Journal of clinical oncology (20.02.2021)
Published in Journal of clinical oncology (20.02.2021)
Get full text
Journal Article